CONTACT
+91 80 2808 2808
info@biocon.com
Generics_Banner-biocon
Biocon  /  Products  /  Generics

GENERICS

Generic Formulations and API products are listed below.

GENERIC FORMULATIONS

Sl. No Molecule Name Status
1 Atorvastatin Commercial (U.S.)
2 Aminocaproic Acid Commercial (U.S.)
3 Dapagliflozin Tentative Approval (U.S.)
4 Dasatinib Approved (Chile)
4 Dorzolamide Commercial (U.S.)
5 Dorzolamide Timolol Approved (U.S.)
6 Esomeprazole Commercial (U.S.)
7 Everolimus (RLD Affinitor) Commercial (U.S. & Mexico), Approved (Europe & Saudi Arabia)
8 Fingolimod (Multiple Sclerosis) Approved (U.S., Europe, U.K., & UAE)
9 Labetalol Commercial (U.S.)
10 Lenalidomide Approved (Europe, U.K.)
11 Mycophenolic Acid Commercial (U.S.) Approved (Singapore)
11 Pemetrexed Tentative Approval (U.S.)
12 Posaconazole Commercial (U.S., U.K.) Approved (Europe)
13 Pravastatin Commercial (U.S.)
14 Rosuvastatin Commercial (U.S., Europe, & Singapore)
15 Simvastatin Commercial (U.S.)
16 Tacrolimus Commercial (U.S., Mexico, & Singapore)
17 Teriflunomide Commercial (U.S.)
18 Vigabatrin Approved (U.S.)

API

Cardiology
Sl. No Molecule Name
1 Simvastatin
2 Pravastatin
3 Atorvastatin
4 Rosuvastatin
5 Fluvastatin
6 Dabigatran
7 Sacubitril/Valsartan
8 Apixaban
9 Rivaroxaban
Anti-Diabetics
Sl. No Molecule Name
1 Vildagliptin
2 Linagliptin
3 Sitagliptin (various salts)
4 Dapagliflozin (different solvate forms)
5 Empagliflozin
6 Repaglinide
7 Liraglutide
8 Semaglutide
Immunosuppressants
Sl. No Molecule Name
1 Tacrolimus
2 Sirolimus
3 Everolimus
4 Pimecrolimus
5 Mycophenolate Mofetil (MMF)
6 Mycophenolate Sodium (MPS)
Multiple Sclerosis
Sl. No Molecule Name
1 Glatiramer Acetate
2 Fingolimod
3 Teriflunomide
Anti-Cancer/Oncology
Sl. No Molecule Name
1 Dasatinib
2 Lenalidomide
3 Pazopanib
4 Erdafitinib
Other Key Products
Sl. No Molecule Name
1 Orlistat
2 Mirabegron
3 Posaconazole
4 Micafungin
5 Anidulafungin
6 Brinzolamide
Siddharth Mittal
KEY MANAGEMENT TEAM
PRESS RELEASES
KMS
OUR LEGACY
CORPORATE GOVERNANCE
SUSTAINABILITY
Share